Advances in Pharmacology series, highlights new advances in the field, with this new volume presenting interesting chapters. Each chapter is written by an international board of authors.
1. Cover image - p. i 2. Table of Contents - p. iii 3. Copyright - p. iii 4. Contributors - p. iii 5. Endocrine disrupting chemicals: Understanding what matters - p. xiii 6. Chapter One: Endocrine disruptor global policy - p. 17 7. Chapter Two: Toxicity testing and endocrine disrupting chemicals - p. 53 8. Chapter Three: Epigenetics, estrogenic endocrine-disrupting chemicals (EDCs), and the brain - p. 73 9. Chapter Four: Endocrine disrupting chemicals (EDCs) and the neuroendocrine system: Beyond estrogen, androgen, and thyroid - p. 101 10. Chapter Five: Endocrine disrupting chemicals and reproductive disorders in women, men, and animal models - p. 151 11. Chapter Six: Endocrine disrupting chemicals (EDCs) and sex steroid receptors - p. 198 12. Chapter Seven: Endocrine disrupting chemicals and the mammary gland - p. 237 13. Chapter Eight: Impact of gestational exposure to endocrine disrupting chemicals on pregnancy and birth outcomes - p. 308 14. Chapter Nine: Endocrine disrupting chemicals (EDCs) and placental function: Impact on fetal brain development - p. 347 15. Chapter Ten: Endocrine disrupting chemicals and thyroid hormone action - p. 401 16. Chapter Eleven: Inappropriately sweet: Environmental endocrine-disrupting chemicals and the diabetes pandemic - p. 427 17. Chapter Twelve: The new kids on the block: Emerging obesogens - p. 465 18. Chapter Thirteen: Endocrine disrupting chemicals and breast cancer cells - p. 489 19. Chapter Fourteen: EDCs and male urogenital cancers - p. 521
Advances in Pharmacology series, highlights new advances in the field, with this new volume presenting interesting chapters. Each chapter is written by an international board of authors.
1. Cover image - p. i 2. Table of Contents - p. iii 3. Copyright - p. iii 4. Contributors - p. iii 5. Endocrine disrupting chemicals: Understanding what matters - p. xiii 6. Chapter One: Endocrine disruptor global policy - p. 17 7. Chapter Two: Toxicity testing and endocrine disrupting chemicals - p. 53 8. Chapter Three: Epigenetics, estrogenic endocrine-disrupting chemicals (EDCs), and the brain - p. 73 9. Chapter Four: Endocrine disrupting chemicals (EDCs) and the neuroendocrine system: Beyond estrogen, androgen, and thyroid - p. 101 10. Chapter Five: Endocrine disrupting chemicals and reproductive disorders in women, men, and animal models - p. 151 11. Chapter Six: Endocrine disrupting chemicals (EDCs) and sex steroid receptors - p. 198 12. Chapter Seven: Endocrine disrupting chemicals and the mammary gland - p. 237 13. Chapter Eight: Impact of gestational exposure to endocrine disrupting chemicals on pregnancy and birth outcomes - p. 308 14. Chapter Nine: Endocrine disrupting chemicals (EDCs) and placental function: Impact on fetal brain development - p. 347 15. Chapter Ten: Endocrine disrupting chemicals and thyroid hormone action - p. 401 16. Chapter Eleven: Inappropriately sweet: Environmental endocrine-disrupting chemicals and the diabetes pandemic - p. 427 17. Chapter Twelve: The new kids on the block: Emerging obesogens - p. 465 18. Chapter Thirteen: Endocrine disrupting chemicals and breast cancer cells - p. 489 19. Chapter Fourteen: EDCs and male urogenital cancers - p. 521
